ArticleWorld journal of surgical oncology2025
Refining distant metastasis stage in oral squamous cell carcinoma.
Article in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lymph node metastasis pattern in recurrent and ipsilateral second primary oral squamous cell carcinoma.Clinical oral investigations · 2026Article
- Prediction of local recurrence in cohorts of head and neck cancer patients after intensity-modulated radiation therapy based on CT radiomics: A double-center observation study.Translational oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThis study aimed to investigate the impact of varying distant metastatic burdens on prognosis in oral squamous cell carcinoma (OSCC) and to propose a novel staging system for distant metastasis.
methodsWe retrospectively enrolled patients with primary stage IVc OSCC at diagnosis or those who developed confirmed distant metastasis within six months after curative treatment. These patients were divided into training and validation cohorts. The prognostic accuracy of the 8th edition AJCC staging system and our proposed staging system was evaluated based on overall survival (OS).
resultsAmong the 586 patients analyzed, 317 were assigned to the training cohort. OS was significantly influenced by the number of metastatic foci and the number of affected anatomic sites, but not by the size of the metastatic foci. Compared to stage IVc1 (defined as ≤ 3 metastatic foci within a single anatomic site), stage IVc2 (4-5 metastatic foci in one site or 2-5 foci across two sites) and stage IVc3 (all other distant metastasis patterns) were associated with hazard ratios of 1.35 (95% CI: 1.10-1.47) and 1.87 (95% CI: 1.51-2.43), respectively. Our proposed model achieved a concordance index of 0.691 and a likelihood ratio of 0.507, demonstrating superior discriminatory ability between patient subgroups and better homogeneity within subgroups compared to the AJCC system. Additionally, the new staging system remained an independent prognostic factor in the validation cohort.
conclusionsIn primary stage IVc OSCC, the extent of distant metastatic burden significantly affects OS. Our novel staging system offers more precise prognostic stratification than the current AJCC classification. However, further validation through prospective studies is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.